Free Trial

Neogen (NEOG) Stock Price, News & Analysis

Neogen logo
$9.28 +0.19 (+2.04%)
Closing price 05/5/2026 03:59 PM Eastern
Extended Trading
$9.28 0.00 (0.00%)
As of 05:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Neogen Stock (NASDAQ:NEOG)

Advanced

Key Stats

Today's Range
$9.09
$9.34
50-Day Range
$8.36
$11.32
52-Week Range
$4.53
$11.43
Volume
1.37 million shs
Average Volume
2.84 million shs
Market Capitalization
$2.02 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.67
Consensus Rating
Hold

Company Overview

Neogen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

NEOG MarketRank™: 

Neogen scored higher than 41% of companies evaluated by MarketBeat, and ranked 368th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Neogen has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside Potential

    Neogen has a consensus price target of $10.67, representing about 15.0% upside from its current price of $9.28.

  • Amount of Analyst Coverage

    Neogen has only been the subject of 2 research reports in the past 90 days.

  • Read more about Neogen's stock forecast and price target.
  • Earnings Growth

    Earnings for Neogen are expected to decrease by -4.35% in the coming year, from $0.23 to $0.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Neogen is -3.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Neogen is -3.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Neogen has a PEG Ratio of 3.95. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Neogen has a P/B Ratio of 0.97. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.63% of the float of Neogen has been sold short.
  • Short Interest Ratio / Days to Cover

    Neogen has a short interest ratio ("days to cover") of 3.03, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Neogen has recently decreased by 0.40%, indicating that investor sentiment is improving.
  • Dividend Yield

    Neogen does not currently pay a dividend.

  • Dividend Growth

    Neogen does not have a long track record of dividend growth.

  • News Sentiment

    Neogen has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Neogen this week, compared to 12 articles on an average week.
  • MarketBeat Follows

    Only 3 people have added Neogen to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Neogen insiders have bought more of their company's stock than they have sold. Specifically, they have bought $252.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.55% of the stock of Neogen is held by insiders.

  • Percentage Held by Institutions

    96.73% of the stock of Neogen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Neogen's insider trading history.
Receive NEOG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neogen and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NEOG Stock News Headlines

Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners guide...please take a few seconds and download it right now before your download link expires. That way, no matter what it costs in the future, you'll have a free copy on your computer.tc pixel
3 Reasons NEOG is Risky and 1 Stock to Buy Instead
See More Headlines

NEOG Stock Analysis - Frequently Asked Questions

Neogen's stock was trading at $6.99 at the beginning of 2026. Since then, NEOG shares have increased by 32.7% and is now trading at $9.2750.

Neogen Corporation (NASDAQ:NEOG) posted its quarterly earnings results on Thursday, April, 9th. The company reported $0.09 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.05. The company's quarterly revenue was down 4.4% compared to the same quarter last year.
Read the conference call transcript
.

Neogen shares split before market open on Tuesday, January 2nd 2018.The 4-3 split was announced on Friday, December 8th 2017. The newly minted shares were distributed to shareholders after the market closes on Friday, December 29th 2017. An investor that had 100 shares of stock prior to the split would have 133 shares after the split.

Neogen's top institutional investors include SG Americas Securities LLC (2.88%), Bank of New York Mellon Corp (0.57%), Principal Financial Group Inc. (0.49%) and Perkins Capital Management Inc. (0.08%). Insiders that own company stock include John Edward Adent, David H Naemura, James C Borel, Douglas Edward Jones, James P Tobin, Amy M Rocklin, Jason Warren Lilly, William T Boehm, Aashima Gupta, John Patrick Moylan and Mikheal Nassif.
View institutional ownership trends
.

Shares of NEOG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neogen investors own include NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
4/09/2026
Today
5/06/2026
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:NEOG
CIK
711377
Employees
2,110
Year Founded
1982

Price Target and Rating

High Price Target
$12.00
Low Price Target
$10.00
Potential Upside/Downside
+15.0%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
40.33
P/E Growth
3.95
Net Income
-$1.09 billion
Net Margins
-69.93%
Pretax Margin
-72.15%
Return on Equity
2.35%
Return on Assets
1.46%

Debt

Debt-to-Equity Ratio
0.38
Current Ratio
3.92
Quick Ratio
2.84

Sales & Book Value

Annual Sales
$894.66 million
Price / Sales
2.26
Cash Flow
$5.87 per share
Price / Cash Flow
1.58
Book Value
$9.54 per share
Price / Book
0.97

Miscellaneous

Outstanding Shares
217,670,000
Free Float
216,476,000
Market Cap
$2.02 billion
Optionable
Optionable
Beta
1.84

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:NEOG) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners